Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area.
There is considerable evidence that drug reward and brain stimulation reward (BSR) share common neural substrates. Although it is known that exposure to drugs of abuse causes a variety of molecular changes in brain reward systems, little is known about the molecular consequences of BSR. We report that repeated exposure to rewarding stimulation of the medial forebrain bundle (MFB) selectively decreases expression of GluR1 (an AMPA receptor subunit) in the VTA, without effect on expression of several other proteins (GluR2, NMDAR1, tyrosine hydroxylase). This effect of BSR on GluR1 expression is opposite of that caused by intermittent exposure to cocaine and morphine, which are known to elevate GluR1 expression in the VTA. Considering that elevated GluR1 expression in the VTA has been associated with increased sensitivity to drug reward, the finding that BSR and drugs of abuse have opposite effects on GluR1 expression in this region may provide an explanation for why the reward-related effects of many drugs (cocaine, morphine, amphetamine, PCP, nicotine) do not sensitize with repeated testing in BSR procedures that quantify reward strength.
Carlezon
W A
WA
Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, USA.
Todtenkopf
M S
MS
McPhie
D L
DL
Pimentel
P
P
Pliakas
A M
AM
Stellar
J R
JR
Trzcinska
M
M
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D015536:Down-Regulation / Q000502:physiology*; D004558:Electric Stimulation; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000096:biosynthesis*; D016194:Receptors, N-Methyl-D-Aspartate / Q000096:biosynthesis; D012201:Reward; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis; D017557:Ventral Tegmental Area / Q000378:metabolism* / Q000502:physiology
D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D014446:Tyrosine 3-Monooxygenase; C104722:glutamate receptor ionotropic, AMPA 2